NXPI Q1 2026 Earnings EPS Tops Estimates Amid Resilient Demand CF Q1 2026 Earnings Strong EPS Beat Offsets Flat Revenue Outlook AVNS Q1 2026 Earnings EPS Surges Past Estimates by 54 RxSight Q1 2026 Earnings EPS Misses Estimates by 32 as Operational Costs Weigh HELE Q1 2026 Earnings EPS Beats Estimates by Over 15 Shares Rise Silo Pharma Inc SILO Q4 2023 Earnings Widening Losses as PreRevenue Biotech Focuses on Pipeline Progress